BRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing

Reuters10-30

BRIEF-BioXcel <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing

Oct 30 (Reuters) - BioXcel Therapeutics Inc BTAI.O:

BIOXCEL THERAPEUTICS INC - UPDATES ON SNDA SUBMISSION FOR IGALMI LABEL EXPANSION - SEC FILING
BIOXCEL THERAPEUTICS INC - EXPECTS SNDA SUBMISSION COMPLETION EARLY Q1 2026 - SEC FILING

Source text: [ID:n0001104659-25-104009]

Further company coverage: BTAI.O

(Reporting by Anhata Rooprai)

((Anhata.Rooprai@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2579148327?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 19:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579148327","market":"us","top_or_hot":-1,"title":"BRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-BioXcel <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing</title></head><body><p><span>Oct 30 (Reuters)</span><span> - </span>BioXcel Therapeutics Inc <span>BTAI.O</span>:</p><ul><li><p>BIOXCEL THERAPEUTICS INC - UPDATES ON SNDA SUBMISSION FOR IGALMI LABEL EXPANSION - SEC FILING</p></li><li><p>BIOXCEL THERAPEUTICS INC - EXPECTS SNDA SUBMISSION COMPLETION EARLY Q1 2026 - SEC FILING</p></li></ul><p>Source text: [ID:n0001104659-25-104009]</p><p>Further company coverage: <span>BTAI.O</span></p><p> (Reporting by Anhata Rooprai)</p><p> ((Anhata.Rooprai@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-30 19:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-BioXcel <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing</title></head><body><p><span>Oct 30 (Reuters)</span><span> - </span>BioXcel Therapeutics Inc <span>BTAI.O</span>:</p><ul><li><p>BIOXCEL THERAPEUTICS INC - UPDATES ON SNDA SUBMISSION FOR IGALMI LABEL EXPANSION - SEC FILING</p></li><li><p>BIOXCEL THERAPEUTICS INC - EXPECTS SNDA SUBMISSION COMPLETION EARLY Q1 2026 - SEC FILING</p></li></ul><p>Source text: [ID:n0001104659-25-104009]</p><p>Further company coverage: <span>BTAI.O</span></p><p> (Reporting by Anhata Rooprai)</p><p> ((Anhata.Rooprai@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WB231:1","article_id":"2579148327","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579148327","pubTimestamp":1761823213,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC FilingOct 30  - BioXcel Therapeutics Inc BTAI.O:BIOXCEL THERAPEUTICS INC - UPDATES ON SNDA SUBMISSION FOR IGALMI LABEL EXPANSION - SEC FILINGBIOXCEL THERAPEUTICS INC - EXPECTS SNDA SUBMISSION COMPLETION EARLY Q1 2026 - SEC FILINGSource text: [ID:n0001104659-25-104009]Further company coverage: BTAI.O  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BTAI":"Bioxcel Therapeutics Inc."},"translate_title":"简介-BioXcel Therapeutics Inc-Igalmi标签扩展sNDA提交的更新-SEC备案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BTAI":0.9},"content_text":"BRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC FilingOct 30 (Reuters) - BioXcel Therapeutics Inc BTAI.O:BIOXCEL THERAPEUTICS INC - UPDATES ON SNDA SUBMISSION FOR IGALMI LABEL EXPANSION - SEC FILINGBIOXCEL THERAPEUTICS INC - EXPECTS SNDA SUBMISSION COMPLETION EARLY Q1 2026 - SEC FILINGSource text: [ID:n0001104659-25-104009]Further company coverage: BTAI.O (Reporting by Anhata Rooprai) ((Anhata.Rooprai@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2579148327","isCrawlerRequest":true}